Bodycote plc (BOY) is a leading specialty industrial machinery business based in the UK. It opened the day at 769.5p after a previous close of 751p. During the day the price has varied from a low of 732p to a high of 769.5p. The latest price was 733p (25 minute delay). Bodycote is listed on the London Stock Exchange (LSE) and employs 5,373 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Bodycote's share price has had significant negative movement.
Its last market close was 657p, which is 22.71% down on its pre-crash value of 850p and 73.63% up on the lowest point reached during the March crash when the shares fell as low as 378.4p.
If you had bought £1,000 worth of Bodycote shares at the start of February 2020, those shares would have been worth £526.31 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £767.05.
|52-week range||360.7p - 923.1974p|
|50-day moving average||744.0883p|
|200-day moving average||643.2958p|
|Wall St. target price||934.06p|
|Dividend yield||0.12p (1.61%)|
|Earnings per share (TTM)||23.3p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-11)||-2.20%|
|1 month (2020-12-18)||733|
|3 months (2020-10-16)||8.35%|
|6 months (2020-07-17)||16.63%|
|1 year (2020-01-17)||-20.07%|
|2 years (2019-01-18)||-6.51%|
|3 years (2018-01-18)||-25.43%|
|5 years (2016-01-18)||43.58%|
Valuing Bodycote stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bodycote's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bodycote's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Bodycote shares trade at around 32x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bodycote's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £176.2 million.
The EBITDA is a measure of a Bodycote's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£659.9 million|
|Operating margin TTM||15.72%|
|Gross profit TTM||£267.4 million|
|Return on assets TTM||5.73%|
|Return on equity TTM||6.25%|
|Market capitalisation||£1.4 billion|
TTM: trailing 12 months
Dividend payout ratio: 14478.26% of net profits
Recently Bodycote has paid out, on average, around 14478.26% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bodycote shareholders could enjoy a 1.61% return on their shares, in the form of dividend payments. In Bodycote's case, that would currently equate to about 0.12p per share.
Bodycote's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 January 2021 (the "ex-dividend date").
Bodycote's shares were split on a 11:19 basis on 9 December 2008. So if you had owned 19 shares the day before before the split, the next day you'd have owned 11 shares. This wouldn't directly have changed the overall worth of your Bodycote shares – just the quantity. However, indirectly, the new 72.7% higher share price could have impacted the market appetite for Bodycote shares which in turn could have impacted Bodycote's share price.
Over the last 12 months, Bodycote's shares have ranged in value from as little as 360.7p up to 923.1974p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Bodycote's is 1.0532. This would suggest that Bodycote's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Bodycote plc provides heat treatment and thermal processing services worldwide. The company operates through Aerospace, Defence & Energy; and Automotive & General Industrial segments. It offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, and vacuum and honeycomb brazing; and hot isostatic pressing (HIP) services, including powdermet technology, isostatic pressing, and HIP supporting. The company also provides surface technologies, which are used to prolong the working life of components and protect from environmental factors, such as corrosion and abrasion. Its surface technologies include anodizing, ceramic, flame and combustion spraying, high velocity oxygen fuel, plasma spray, and thermo-chemically formed ceramic coatings to enhance wear resistance. The company serves automotive, aerospace and defense, energy, and general industrial markets. Bodycote plc was founded in 1923 and is headquartered in Macclesfield, the United Kingdom.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ever wondered how to buy shares in Van Elle Holdings? We explain how and compare a range of providers that can give you access to many brands, including Van Elle Holdings.
Ever wondered how to buy shares in ULS Technology? We explain how and compare a range of providers that can give you access to many brands, including ULS Technology.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.